Production (Stage)
Century Therapeutics, Inc.
IPSC
$0.583
$0.00761.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.56M | -36.07M | -31.22M | -31.21M | -28.06M |
| Total Depreciation and Amortization | 3.22M | 3.32M | 3.30M | 3.46M | 3.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.81M | 7.66M | 1.41M | -300.00K | 3.63M |
| Change in Net Operating Assets | -116.21M | 871.00K | -1.82M | 713.00K | -9.05M |
| Cash from Operations | -34.62M | -24.22M | -28.33M | -27.33M | -30.25M |
| Capital Expenditure | -475.00K | -154.00K | 804.00K | -265.00K | -539.00K |
| Sale of Property, Plant, and Equipment | -- | -21.00K | 21.00K | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -9.61M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.41M | 30.78M | 38.37M | -23.99M | 12.08M |
| Cash from Investing | 27.93M | 30.61M | 39.20M | -33.86M | 11.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 120.00K | -- | 74.70M | 104.00K | 366.00K |
| Repurchase of Common Stock | -- | -602.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -74.42M | 56.59M | 17.83M |
| Cash from Financing | 120.00K | -602.00K | 273.00K | 56.70M | 18.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.57M | 5.78M | 11.14M | -4.50M | -512.00K |